Kinarus Therapeutics - USPTO allows method-of-use KIN001 patent
Kinarus received a notice of allowability from the US Patent and Trademark Office (USPTO) for its patent application No. 16/500,504 (‘methods of preventing or treating ophthalmic diseases’) covering its orally dosed lead drug candidate KIN001 for its lead indication to treat wet age-related macular degeneration (wet AMD). This method of use patent is on top of the USPTO-granted composition-of-matter Patent No. 11285155, which is designed to protect the KIN001 pharmaceutical combination of pamapimod and pioglitazone until at least 2037. We view this development as positive for Kinarus as it strengthens the intellectual property position of KIN001 as the company works towards starting a Phase II study with the drug in wet AMD in the coming months, upon the attainment of the necessary financing.Perfect Holding SA. Perfect Holding SA is a Switzerland-based company that focuses on the acquisition and management of investments in companies, which are active in the aircraft management and related services sector. The Company operates under four business divisions: optical disc, aircraft management, charters and brokerage. Perfect Holding SA, through its subsidiaries, is dedicated to the provision of services to the business aircraft market such as aircraft management, aircraft sales, charter sales and travel services. The Company manages medium- to large-business aircrafts, such as Bombardier Global and Challenger jets. The Company wholly owns three subsidiaries, including Perfect Aviation SA, based in Switzerland, Perfect Aviation Portugal SA, based in Portugal and Perfect Aviation UK Ltd, based in the United Kingdom.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.